We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Ultra-Fast Real-Time PCR Platform Could Revolutionize POC Molecular Diagnostics

By LabMedica International staff writers
Posted on 08 Nov 2022

An ultra-fast point-of-care real-time PCR platform for infectious disease diagnostics that is currently under development will be able to deliver results within five minutes at a cost equivalent to antigen tests currently available in the market. More...

Using proprietary technologies, LEX Diagnostics (Melbourn, UK) is developing a platform that could revolutionize point-of-care molecular diagnostics with a step change in speed, sensitivity and cost. The LEX System being developed by LEX Diagnostics aims to deliver true-PCR insights to clinicians at the time they are most valuable, meaning an answer in 5-7 minutes. Amplifying the genetic material over tens of thermal cycles is the bottleneck for conventional PCR systems. LEX’s amplification chambers can be heated or cooled in seconds. The company’s IP enables ultrafast thermocycling without the need for an expensive, unreliable Peltier cooler. This enables a compact, robust reader with a low cost of goods.

RT-PCR is the gold standard for the diagnosis of viral infectious disease. LEX has shown that its platform amplifies viruses with lab-standard sensitivity and selectivity. LEX’s IP protects a cartridge design that can be made from industry standard materials developed by experienced engineers to be within standard process tolerances. The LEX System is compact enough to fit on the bench of the smallest physician’s office lab and simple enough to be used by the newest nurse or the oldest doctor in the practice. It will deliver results quickly enough to support the busiest urgent care yet is affordable enough for the smallest rural pharmacy.

Related Links:
LEX Diagnostics 


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.